Vcare can provide clients with one-stop services of R&D of innovative medicines and generics and quality consistency evaluation for generics.
Clinical services provided by Vcare include Phase I, Phase II, Phase III, Phase IV trials for innovative medicines and bioequivalence trials for generic medicines.
Vcare provides clients with research and development, technical transformation and optimization, manufacture and sales of a series of advanced pharmaceutical intermediates.
We can sustainably supply legally compliable and high-quality intermediate to local and multi-national company. Also we can provide adequate services including research of related substances, validation of analytical method and stability test.
Vcare’s self-owned API manufacture base allow us to provide legally compliable and high-quality product to customers. Also, we can submit research and analytical method of related substances.
Vcare can provide customized service of nearly 100 strictly analyzed drug impurities. We can provide NMR, MS, HPLC spectrum of all those products.
The phase II study of our core product Vicagrel will complete soon, our research & develop pipeline is plentiful regarding the follow-up innovative project of second echelon.
Vcare can provide customers with one-stop research service including R&D of advanced pharmaceutical intermediate, API, analytical, formulation and clinical, thus helping customers manage the whole lifecycle of the product.
The company now has one Yangtze River Scholar professor. We’ve already built a R&D team of 200 members, 40 percent of them got Master`s Degree or above. Based on this professional team, we have successfully launched several generic drugs together with our companion.
